Desmopressin Acetate Spray Shortage: Current Supply Updates and Manufacturer Status
The FDA has reported a current shortage of Desmopressin Acetate Spray due to shipping delays, with replenishment from Apotex Corp. expected in mid-March 2026.
What’s in Shortage
Desmopressin Acetate Spray (Brand Name: DESMOPRESSIN ACETATE) is currently listed in shortage. This medication is used within the Hematology therapeutic category and is supplied as a spray in a 10 ug dosage form (NDC 60505-0815-0).
Which Manufacturers Are Affected
Apotex Corp.
- Status: Unavailable
- Notes: The next replenishment is currently expected in Mid March 2026. This specific presentation of Desmopressin Acetate does not require refrigeration.
- Contact Information: 800-706-5575
Why There’s a Shortage
The shortage is due to a delay in shipping of the drug. No further details regarding the logistics delay were provided in the official report.
What Patients Should Do
If you are currently prescribed Desmopressin Acetate Spray, please consider the following steps:
- Consult your healthcare provider: Discuss your treatment plan and ask about suitable alternatives for your condition.
- Talk to your pharmacist: Check on local stock levels and see if they can assist in locating the medication at other branches.
- Contact the manufacturer: You may reach out to Apotex Corp. at 800-706-5575 for specific questions regarding their supply timeline.
Disclaimer: Patients should always consult their healthcare provider for medical advice and treatment options. Do not change your medication regimen without professional guidance.
Source
Information sourced from the FDA Drug Shortage Database.
- Initial Posting Date: 03/12/2021
- Last Updated: 03/04/2026
Source: FDA Official Notice
Related Articles
Albuterol Sulfate Solution Shortage: Latest Updates and Availability
FDA · March 3, 2026
Sufentanil Citrate Injection Shortage: Current Availability and Manufacturer Updates
FDA · February 17, 2026
Penicillin G Benzathine (Bicillin L-A) Injection Shortage: Latest Updates and Availability
FDA · February 17, 2026